We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+15.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$618M
AUM Growth
+$153M
Cap. Flow
+$172M
Cap. Flow %
27.88%
Top 10 Hldgs %
4.55%
Holding
1,094
New
391
Increased
237
Reduced
151
Closed
315

Top Buys

Rank Stock Value
1
DAR icon
Darling Ingredients
DAR
+$3.15M
2
KEYS icon
Keysight
KEYS
+$3M
3
BDX icon
Becton Dickinson
BDX
+$2.85M
4
TREX icon
Trex
TREX
+$2.79M
5
KO icon
Coca-Cola
KO
+$2.74M

Top Sells

Rank Stock Value
1
PVH icon
PVH
PVH
+$2.16M
2
TWLO icon
Twilio
TWLO
+$2.16M
3
MPWR icon
Monolithic Power Systems
MPWR
+$2.16M
4
CB icon
Chubb
CB
+$2.15M
5
SPGI icon
S&P Global
SPGI
+$2.15M

Sector Composition

Rank Sector Weight
1 Industrials 18.44%
2 Technology 16.09%
3 Financials 12.33%
4 Healthcare 12.1%
5 Consumer Discretionary 11.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MD icon
776
Pediatrix Medical
MD
$2.18B
$79.6K 0.01%
+10,540
New +$87.2K
PGRE
777
DELISTED
Paramount Group
PGRE
$73.7K 0.01%
15,926
-34,153
-68% -$158K
ADPT icon
778
Adaptive Biotechnologies
ADPT
$3.6B
$54.3K 0.01%
15,011
-9,339
-38% -$29.6K
BDN
779
Brandywine Realty Trust
BDN
$528M
$46.7K 0.01%
10,428
-39,244
-79% -$179K
AAL icon
780
American Airlines Group
AAL
$10.1B
-69,310
Closed -$1.06M
ACGL icon
781
Arch Capital
ACGL
$37.1B
-6,995
Closed -$647K
ACM icon
782
Aecom
ACM
$9.66B
-18,663
Closed -$1.83M
ADC icon
783
Agree Realty
ADC
$9.71B
-24,375
Closed -$1.39M
AES icon
784
AES
AES
$10.6B
-91,109
Closed -$1.63M
AFRM icon
785
Affirm
AFRM
$24.2B
-21,698
Closed -$808K
AGIO icon
786
Agios Pharmaceuticals
AGIO
$2.13B
-34,855
Closed -$1.02M
ALE
787
DELISTED
Allete
ALE
-5,019
Closed -$299K
ALHC icon
788
Alignment Healthcare
ALHC
$3.86B
-12,296
Closed -$61K
ALLO icon
789
Allogene Therapeutics
ALLO
$563M
-115,988
Closed -$518K
AMD icon
790
Advanced Micro Devices
AMD
$743B
-3,545
Closed -$640K
ANGI icon
791
Angi Inc
ANGI
$253M
-4,273
Closed -$112K
APOG icon
792
Apogee Enterprises
APOG
$872M
-6,031
Closed -$357K
APTV icon
793
Aptiv
APTV
$12.5B
-24,031
Closed -$1.91M
ARDX icon
794
Ardelyx
ARDX
$1.25B
-34,179
Closed -$250K
ARHS icon
795
Arhaus
ARHS
$1.13B
-16,042
Closed -$247K
ARLO icon
796
Arlo Technologies
ARLO
$1.55B
-22,459
Closed -$284K
ARQT icon
797
Arcutis Biotherapeutics
ARQT
$3.52B
-11,100
Closed -$110K
ARRY icon
798
Array Technologies
ARRY
$801M
-25,608
Closed -$382K
AUR icon
799
Aurora
AUR
$11.5B
-26,497
Closed -$74.7K
AVB icon
800
AvalonBay Communities
AVB
$27.4B
-1,761
Closed -$327K

Similar funds

Nebula Research & Development's Q2 2024 Portfolio in Review

As of Q2 2024, Nebula Research & Development held 1,094 positions worth $618M, up 33% from $464M the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Nebula Research & Development deployed $172M of net new capital in Q2 2024, opening 391 new positions and adding to 237 existing holdings. Its largest new stake was Darling Ingredients: 76,060 shares worth $2.8M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $2.12M trimmed.

  • Nebula Research & Development's largest Q2 2024 buy was Darling Ingredients: 76,060 shares worth $2.8M.
  • Nebula Research & Development added most to General Dynamics in Q2 2024, an estimated $2.57M increase.
  • Nebula Research & Development's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.12M.
  • Nebula Research & Development fully exited PVH in Q2 2024, selling an estimated $2.16M.
  • Nebula Research & Development's ten largest holdings make up 4.6% of its $618M portfolio in Q2 2024.
  • Nebula Research & Development opened 391 new positions and closed 315 in Q2 2024.
  • Nebula Research & Development's portfolio value rose 33% quarter-over-quarter to $618M.

Based on Nebula Research & Development's 13F filing for Q2 2024, filed 14 Aug 2024.